Vanta Bioscience Ltd. (VANTABIO)
Market Closed
16 Oct, 10:00 PM
MSE MSE Primary ₹
20. 40
-0.02
-0.0979%
₹
118.7M Market Cap
38.68 P/E Ratio
- Div Yield
1,500 Volume
0 Eps
₹ 20.42
Previous Close Want to track VANTABIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VANTABIO closed today lower at ₹20.4, a decrease of -0.0979% from yesterday's close, completing a monthly decrease of -5.1163% or -₹1.1. Over the past 12 months, VANTABIO stock lost -8.3146%.
VANTABIO is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
VANTABIO Chart
People also search for
Vanta Bioscience Ltd. (VANTABIO) FAQ
What is the stock price today?
The current price is ₹20.40.
On which exchange is it traded?
Vanta Bioscience Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is VANTABIO.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 118.7M.
Has Vanta Bioscience Ltd. ever had a stock split?
No, there has never been a stock split.
Vanta Bioscience Ltd. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | MSE Exchange | INE695X01011 ISIN |
| India Country | 36 Employees | - Last Dividend | - Last Split | - IPO Date |
Vanta Bioscience Ltd. is a preclinical contract research organization (CRO) that plays a pivotal role in the life sciences sector by providing a wide range of comprehensive safety assessment studies. These studies are critical for the evaluation of pharmaceutical, agrochemical, and chemical products, aiding companies in the drug development process and ensuring compliance with regulatory standards. The company focuses on toxicology research, offering expertise in general toxicology, genetic toxicology, and ecotoxicology, among others. Additionally, they provide consulting services related to drug safety and efficacy assessment. With its commitment to delivering high-quality research and maintaining rigorous standards, Vanta Bioscience Ltd. supports various industries by enhancing the reliability of their product safety data, which ultimately contributes to public health and safety. As a player in the dynamic field of biosciences, the company's services are indispensable for clients involved in the intricate process of bringing new therapies and products to market.
Contact Information
Address: No. 02/G/308/G, No.3/FF/SF/1-20-248
Phone: 91 40 6657 5454
Website: https://www.vantabio.com
2026 © Marketlog. All Rights Reserved.
